Big data is changing the way healthcare is delivered and improving the way drugs are developed. But how exactly does big data benefit drug development? Anju’s Chief Technology Officer Joe Alea recently answered that question in Contract Pharma. Read the full article here to learn more about the emerging role of automation, data analytics, and AI in the healthcare industry, and how polluted data lakes impact AI in pharma.
As Chief Technology Officer at Anju Software, Joe Alea leads our product development and services. He has over 30 years of clinical, healthcare, and data analytics experience. Before joining Anju, Joe served in multiple executive roles, including Global VP of Development at Oracle/Phase Forward, and he served as Chief Technology Officer of Clinical Ink.